Skip to main content

Table 3 Adjusted odds ratios of having severe depression or anxiety symptoms associated with DII among men and women

From: Association between Dietary Inflammatory Index (DII®) and depression and anxiety in the Mashhad Stroke and Heart Atherosclerotic Disorder (MASHAD) Study population

Gender

DII (Q1 = reference group)

Depression severity risk (minimal depression quartile as the reference group)

Reference group and mildly affected group

Reference group and moderately affected group

Reference group and severely affected group

OR

95% CI

Sig.

OR

95% CI

Sig.

OR

95% CI

Sig.

Male

Q2

0.74

0.55–1

0.051

0.81

0.57–1.16

0.254

1.27

0.74–2.15

0.381

Q3

0.87

0.66–1.15

0.335

1.14

0.82–1.57

0.441

0.97

0.56–1.68

0.922

Q4

1.15

0.87–1.53

0.323

1.22

0.86–1.72

0.260

1.11

0.63–1.96

0.723

Female

Q2

0.92

0.77–1.10

0.369

0.91

0.74–1.11

0.356

1.23

0.92–1.64

0.171

Q3

1.02

0.85–1.22

0.849

1.07

0.87–1.31

0.534

1.41

1.06–1.88

0.019

Q4

1.16

0.98–1.39

0.089

1.12

0.92–1.37

0.257

1.37

1.03–1.83

0.032

Gender

DII (Q1 = reference group)

Anxiety severity risk (minimal anxiety quartile as the reference group)

Reference group and mildly affected group

Reference group and moderately affected group

Reference group and severely affected group

OR

95% CI

Sig.

OR

95% CI

Sig.

OR

95% CI

Sig.

Male

Q2

1.24

0.97–1.58

0.091

0.91

0.64–1.29

0.601

0.88

0.56–1.38

0.585

Q3

1.20

0.94–1.53

0.144

1.15

0.83–1.59

0.400

0.67

0.42–1.07

0.093

Q 4

1.22

0.94–1.59

0.127

1.09

0.76–1.55

0.647

1.21

0.78–1.87

0.400

Female

Q2

1.06

0.86–1.32

0.579

1.04

0.81–1.33

0.772

1.20

0.89–1.62

0.234

Q3

1.06

0.85–1.32

0.603

0.96

0.74–1.24

0.731

1.07

0.78–1.47

0.657

Q4

1.08

0.88–1.33

0.471

0.95

0.74–1.22

0.705

1.33

1–1.78

0.052

  1. Abbreviations: Q quartile, OR odds ratio, CI confidence interval
  2. ORs were adjusted for age (35–44, 45.54 and 55–65), body mass index, smoking status, education level, marital status, physical activity level, high sensitivity C-reactive protein, and dyslipidemia